Clinical Trials on Plasma Homocysteine in New Zealand
Total 885 results
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Genzyme, a Sanofi CompanyAnorMEDTerminatedMultiple MyelomaUnited States
-
Celularity IncorporatedCompleted
-
Seagen Inc.Terminated
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCCompleted
-
Hackensack Meridian HealthOnyx Therapeutics, Inc.CompletedWaldenstrom MacroglobulinemiaUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Israel
-
Columbia UniversityCephalonCompletedAL AmyloidosisUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple Myeloma | Plasmacytoma | Plasmacytoma of BoneUnited States
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Yale UniversityCelgene; Kyowa Kirin Co., Ltd.Completed
-
UnionDermSkin of Color Society; Solta Medical; ScientisRecruiting
-
Cynosure, Inc.CompletedMelasmaUnited States
-
Sadick Research GroupEpisciences, Inc.Completed
-
AllerganCompleted
-
Adriana RossiNot yet recruitingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
NYU Langone HealthCelgene CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminated
-
Sorrento Therapeutics, Inc.Active, not recruitingMultiple MyelomaUnited States
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; Fox Chase Cancer Center; GlaxoSmithKline and other collaboratorsCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Karyopharm Therapeutics IncCompletedMultiple Myeloma | Relapsed and/or Refractory Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
Rajshekhar Chakraborty, MDHope FoundationRecruiting
-
Thomas Martin, MDSanofi; AmgenActive, not recruitingMultiple MyelomaUnited States, Canada
-
SanofiCompletedPlasma Cell MyelomaUnited States, Czechia, France
-
Rajshekhar Chakraborty, MDGenentech, Inc.RecruitingAL AmyloidosisUnited States
-
Celularity IncorporatedActive, not recruitingCardiovascular Diseases | Vascular Diseases | Neoplasms | Immune System Diseases | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Immunoproliferative Disorders | Hematologic Diseases | Hemorrhagic Disorders | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Antineoplastic Agents | Physiological... and other conditionsUnited States
-
Hackensack Meridian HealthCompletedMultiple Myeloma | Auto Stem Cell TransplantUnited States
-
Dartmouth-Hitchcock Medical CenterThe Leukemia and Lymphoma SocietyCompletedMyeloma | Transplant-eligible PatientsUnited States
-
Promontory Therapeutics Inc.CompletedMultiple MyelomaUnited States
-
Cynosure, Inc.Terminated
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Ajai ChariAmgenCompletedRefractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Senesco Technologies, Inc.UnknownMultiple Myeloma | Plasma Cell Leukemia | Multiple Myeloma in Relapse | Mantle Cell Lymphoma in Relapse | Diffuse Large B Cell Lymphoma in Relapse | Other B Cell Lymphoma in RelapseUnited States, South Africa
-
Ajai ChariCelgene CorporationCompletedMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedWaldenström MacroglobulinemiaUnited States
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, Canada, United Kingdom, Israel, Singapore, New Zealand, Brazil
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)WithdrawnLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Icahn School of Medicine at Mount SinaiRecruiting
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Hartford HospitalCompleted
-
University of NebraskaRecruiting
-
Focus Medical, LLCCompleted
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncTerminatedRefractory Multiple Myeloma | Myeloma | Myeloma MultipleUnited States
-
Astex Pharmaceuticals, Inc.Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
SkylineDxMedex15Active, not recruiting